Literature DB >> 18809469

Proteolytic activity during cortical development is distinct from that involved in hypoxic ischemic injury.

H S Ranasinghe1, C E Williams, L J Christophidis, M D Mitchell, M Fraser, A Scheepens.   

Abstract

Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases involved in brain development and the etiology of adult cerebral injuries. In this study, we determined the MMP-2 and 9 responses following hypoxic ischemia (HI) injury in the developing brain. First, we characterized the developmental changes of MMP activity in the rat brain from embryonic day 18 (E18) to postnatal day 120 (P120). MMP-2 activity was high from E18 to P3 and decreased with age (P< or =0.001), while MMP-9 activity was not detectable. MMP-2 immunoreactivity was closely associated with differentiating cortical plate and subplate neurons. Next, we characterized the proteolytic changes after unilateral HI brain injury in 3- (P3) and 21- (P21) day-old rats. Zymography revealed that in the P21 rat brain, MMP-9 activity (150 and 92 kDa forms) was increased at 6 h and remained elevated 24 h post-injury in the ipsilateral injured hemisphere (P< or =0.001), whereas there was a gradual increase in MMP-2 (65 kDa) activity, reaching a peak at 5 days (P< or =0.001). Similarly, quantitative real time polymerase chain reaction (qRT-PCR) indicated significant elevations in MMP-9 and MMP-2 mRNA expression in the injured cortex (P< or =0.05) and hippocampus (P< or =0.05) at 1 and 5 days post-injury, respectively in the P21 rat brain. In the P3 rat brain, zymography results revealed that both pro (92 kDa) and cleaved (87 kDa) MMP-9 activities were upregulated in the ipsilateral injured hemisphere from 6 h to 1 day after injury (P< or =0.001). In contrast, cleaved MMP-2 (60 kDa) was only moderately upregulated at 6 h (P< or =0.01), while pro MMP-2 (65 kDa) levels were unaffected. MMP-9 mRNA expression was also increased at 6 h (P< or =0.05) following injury at P3, whereas MMP-2 expression remained unchanged compared with the uninjured contralateral hemisphere. Immunohistochemistry indicated that MMP-9 protein expression was localized predominantly to neurons and peri-vascular astrocytes in the affected regions at early time points, whereas MMP-2 was present on reactive astrocytes surrounding the infarct at later time points. Together, these results indicate that MMP-2 may be primarily associated with the development and differentiation of cortical plate neurons and wound recovery processes. Conversely, MMP-9 appeared to be associated with more acute processes during the period of lesion development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18809469     DOI: 10.1016/j.neuroscience.2008.07.069

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  10 in total

Review 1.  Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?

Authors:  Santiago Rivera; Michel Khrestchatisky; Leszek Kaczmarek; Gary A Rosenberg; Diane M Jaworski
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

2.  Integrin β8 signaling in neonatal hypoxic-ischemic brain injury.

Authors:  Li Zhang; Yi Qu; Binzhi Tang; Fengyan Zhao; Tao Xiong; Donna Ferriero; Dezhi Mu
Journal:  Neurotox Res       Date:  2012-01-25       Impact factor: 3.911

3.  Cognitive Impairment and Brain and Peripheral Alterations in a Murine Model of Intraventricular Hemorrhage in the Preterm Newborn.

Authors:  Antonio Segado-Arenas; Carmen Infante-Garcia; Isabel Benavente-Fernandez; Daniel Sanchez-Sotano; Juan Jose Ramos-Rodriguez; Almudena Alonso-Ojembarrena; Simon Lubian-Lopez; Monica Garcia-Alloza
Journal:  Mol Neurobiol       Date:  2017-07-28       Impact factor: 5.590

4.  Matrix metalloproteinases 2 and 9 fail to influence drug-induced neuroapoptosis in developing rat brain.

Authors:  Ortrud Uckermann; Hella Luksch; Vanya Stefovska; Yvonne Hoehna; Jenny Marzahn; Marlen Theil; Mila Pesic; Tomasz Górkiewicz; Maciej Gawlak; Grzegorz M Wilczynski; Leszek Kaczmarek; Chrysanthy Ikonomidou
Journal:  Neurotox Res       Date:  2010-07-27       Impact factor: 3.911

5.  Differential responses of hippocampal neurons and astrocytes to nicotine and hypoxia in the fetal guinea pig.

Authors:  Tamara Blutstein; Michael A Castello; Shaun S Viechweg; Maria M Hadjimarkou; Joseph A McQuail; Mary Holder; Loren P Thompson; Jessica A Mong
Journal:  Neurotox Res       Date:  2012-11-29       Impact factor: 3.911

6.  Resuscitation of newborn piglets. short-term influence of FiO2 on matrix metalloproteinases, caspase-3 and BDNF.

Authors:  Rønnaug Solberg; Else Marit Løberg; Jannicke H Andresen; Marianne S Wright; Eliane Charrat; Michel Khrestchatisky; Santiago Rivera; Ola Didrik Saugstad
Journal:  PLoS One       Date:  2010-12-09       Impact factor: 3.240

7.  Deafferentation-induced redistribution of MMP-2, but not of MMP-9, depends on the emergence of GAP-43 positive axons in the adult rat cochlear nucleus.

Authors:  Michaela Fredrich; Robert-Benjamin Illing
Journal:  Neural Plast       Date:  2011-10-23       Impact factor: 3.599

8.  Methodologic recommendations and possible interpretations of video-EEG recordings in immature rodents used as experimental controls: A TASK1-WG2 report of the ILAE/AES Joint Translational Task Force.

Authors:  Ozlem Akman; Yogendra H Raol; Stéphane Auvin; Miguel A Cortez; Hana Kubova; Marco de Curtis; Akio Ikeda; F Edward Dudek; Aristea S Galanopoulou
Journal:  Epilepsia Open       Date:  2018-10-11

9.  A PKC-dependent recruitment of MMP-2 controls semaphorin-3A growth-promoting effect in cortical dendrites.

Authors:  Bertrand Gonthier; Eric Koncina; Saulius Satkauskas; Martine Perraut; Guy Roussel; Dominique Aunis; Josef P Kapfhammer; Dominique Bagnard
Journal:  PLoS One       Date:  2009-04-08       Impact factor: 3.240

Review 10.  Hypoxic-ischemic-related cerebrovascular changes and potential therapeutic strategies in the neonatal brain.

Authors:  Clémence Disdier; Barbara S Stonestreet
Journal:  J Neurosci Res       Date:  2020-02-14       Impact factor: 4.164

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.